UB Paderborn / Katalog / Suche / in CDI

1 – 15 von 15

Sortiert nach

Type I Cryoglobulinemic Vasculitis

The New England journal of medicine, 2023-06, Vol.388 (25), p.2378-2378

2023

Volltextzugriff (PDF)

Identification of high oxygen affinity hemoglobin variants in the investigation of patients with erythrocytosis

Haematologica (Roma), 2009-09, Vol.94 (9), p.1321-1322

2009

Volltextzugriff (PDF)

Epidemiology of chronic lymphocytic leukaemia in an Irish subpopulation with total case ascertainment: an additional tool for health economic planning

British journal of haematology, 2022-03, Vol.196 (5), p.e47-e49

2022

Volltextzugriff (PDF)

Low CD49d expression in newly diagnosed chronic lymphocytic leukaemia may be associated with high‐risk features and reduced treatment‐free‐intervals

European journal of haematology, 2022-11, Vol.109 (5), p.441-446

2022

Volltextzugriff (PDF)

Large granular lymphocyte leukemia: natural history and response to treatment

Leukemia & lymphoma, 2010-05, Vol.51 (5), p.839-845

2010

Volltextzugriff (PDF)

Simple methods of preventing cytotoxic disasters

British journal of haematology, 2000-09, Vol.110 (3), p.753-753

Crotty, Gerard M.

2000

Volltextzugriff (PDF)

Methylprednisolone in advanced chronic lymphocytic leukaemia: rationale for, and effectiveness of treatment suggested by DiSC assay

Acta haematologica, 1995-01, Vol.93 (2-4), p.73

1995

Volltextzugriff (PDF)

A Noninterventional, Observational, European Post-Authorization Safety Study of Patients With Relapsed/Refractory Multiple Myeloma Treated With Lenalidomide

Clinical lymphoma, myeloma and leukemia, 2020-10, Vol.20 (10), p.e629-e644

2020

Volltextzugriff (PDF)

Turning the Heat up a Notch in Biclonal Lymphoproliferative Disorders

Blood, 2016-12, Vol.128 (22), p.5569-5569

2016

Volltextzugriff (PDF)

Evaluation of bone marrow examinations performed by an advanced nurse practitioner: An extended role within a haematology service

European journal of oncology nursing : the official journal of European Oncology Nursing Society, 2011-09, Vol.15 (4), p.335-338

2011

Volltextzugriff (PDF)

Clonal karyotypic abnormalities in Philadelphia negative cells of CML patients treated with imatinib: is it under‐reported and does it have any clinical significance?

British journal of haematology, 2004-11, Vol.127 (3), p.367-369

2004

Volltextzugriff (PDF)

1 – 15 von 15

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(15)
Mit Volltextzugriff
(12)

Publikationsform

Artikel
(15)

Sprache

Englisch
(15)

Erscheinungsjahr

n.n

Menü

Weitere Dienste

Einstellungen

Type I Cryoglobulinemic Vasculitis

Identification of high oxygen affinity hemoglobin variants in the investigation of patients with erythrocytosis

Epidemiology of chronic lymphocytic leukaemia in an Irish subpopulation with total case ascertainment: an additional tool for health economic planning

Phase 2 studies of lenalidomide, subcutaneous bortezomib, and dexamethasone as induction therapy in patients with newly diagnosed multiple myeloma

Low CD49d expression in newly diagnosed chronic lymphocytic leukaemia may be associated with high‐risk features and reduced treatment‐free‐intervals

Large granular lymphocyte leukemia: natural history and response to treatment

Simple methods of preventing cytotoxic disasters

Methylprednisolone in advanced chronic lymphocytic leukaemia: rationale for, and effectiveness of treatment suggested by DiSC assay

A Noninterventional, Observational, European Post-Authorization Safety Study of Patients With Relapsed/Refractory Multiple Myeloma Treated With Lenalidomide

Turning the Heat up a Notch in Biclonal Lymphoproliferative Disorders

Risk adjusted therapy in chronic lymphocytic leukemia: a phase II cancer trials Ireland (CTRIAL-IE [ICORG 07-01]) study of fludarabine, cyclophosphamide, and rituximab therapy evaluating response adapted, abbreviated frontline therapy with FCR in non-del(17p) CLL

Minimal Residual Disease (MRD) Status in FCR-Treated CLL Patients at the End of Treatment Influences Progression Free Survival (PFS), Results of the Ctrial-IE (ICORG) 07-01/ CLL Ireland Study, with Mutational Analysis Providing Additional Insight

A Phase II Multi-Center Study of Lenalidomide, Subcutaneous Bortezomib and Dexamethasone (RsqVD) in Newly Diagnosed Multiple Myeloma - Ctrial-IE (ICORG) 13-17 Study

Evaluation of bone marrow examinations performed by an advanced nurse practitioner: An extended role within a haematology service

Clonal karyotypic abnormalities in Philadelphia negative cells of CML patients treated with imatinib: is it under‐reported and does it have any clinical significance?

Suchergebnisse filtern